Office International des Epizooties/National Reference Laboratory for Classical Swine Fever, China Institute of Veterinary Drug Control, Beijing 100081, People's Republic of China.
Boehringer Ingelheim Vetmedica (China) Co. Ltd., Taizhou 225300, People's Republic of China.
Vet Microbiol. 2021 Feb;253:108915. doi: 10.1016/j.vetmic.2020.108915. Epub 2020 Nov 5.
Classical swine fever is an important swine disease in China, and sporadic outbreaks with mild clinical signs despite compulsory vaccination have raised questions about the virulence and pathogenicity of prevalent subgenotype 2.1 strains, and the ability of C-strain vaccines to cross-protect against them. To investigate this, three field isolates were evaluated in experimentally infected piglets and compared with the highly virulent reference Shimen strain. Clinical signs for the field strains ranged from mild to severe, and mortality ranged from 0 to 80 %. These data show differences in virulence among the subgenotype 2.1 field isolates and support the use of field strain GD191 as a genotype 2 challenge virus to assess efficacy of C-strain vaccines. In contrast to the historical genotype 1 strain, which caused acute infection with significant virus shedding in non-vaccinated animals, the subgenotype 2.1 GD191 strain produced different clinical manifestations in weaned piglets and adults. Adult pigs showed subclinical infection with viral shedding, whereas weaned piglets showed overt signs of infection. Efficacy of, and duration of immunity conferred by a C-strain vaccine were assessed using the reference Shimen strain and field isolate GD191 at 12 and 15 months after vaccination. A robust antibody response and sterilising protection were seen in all vaccinated animals and lasted up to 15 months post-vaccination. This study confirms that C-strain vaccines confer both clinical and virological protection against the historical genotype 1 Shimen strain and cross-protection against the prevalent genotype 2 field strain.
古典猪瘟是中国的一种重要猪病,尽管强制接种疫苗,但仍有散发性轻度临床症状的暴发,这引发了人们对流行的 2.1 亚组基因型菌株的毒力和致病性以及 C 株疫苗对它们的交叉保护能力的质疑。为了研究这一点,我们在实验感染的仔猪中评估了三个田间分离株,并将其与高毒力的参考石门株进行了比较。田间分离株的临床症状从轻度到重度不等,死亡率从 0 到 80%不等。这些数据表明,2.1 亚组田间分离株之间存在毒力差异,并支持使用田间分离株 GD191 作为 2 型挑战病毒来评估 C 株疫苗的效力。与引起未接种动物急性感染和显著病毒脱落的历史 1 型株不同,2.1 亚组 GD191 株在断奶仔猪和成年猪中产生了不同的临床表现。成年猪表现为亚临床感染,病毒脱落,而断奶仔猪则表现出明显的感染迹象。我们使用参考石门株和田间分离株 GD191 在接种后 12 个月和 15 个月评估了 C 株疫苗的效力和免疫持续时间。所有接种动物均产生了强大的抗体反应和杀菌保护作用,持续至接种后 15 个月。本研究证实,C 株疫苗对历史 1 型石门株具有临床和病毒学保护作用,并对流行的 2 型田间株具有交叉保护作用。